
A New Weapon Against IgA Nephropathy?
What the Latest China Trial Data Means for You
Living with CKD By Ewerton, founder of MetaSano A weekly newsletter with practical tips, science-based insights, and personal stories to help you slow CKD progression and live well.
Live Last read · last published · next check

What the Latest China Trial Data Means for You

A new scientific opinion asks whether chronic pain is more than just a symptom of kidney disease — and what that could mean for how we manage both.

How everyday habits — activity, sleep, connection, and more — may help lower dementia risk in kidney disease

A New Study Explains Why Potassium Matters So Much for Blood Pressure

A simple skill that protects your kidneys, your wallet, and your taste buds

Separating real evidence from the claims you've probably heard

Today is the day.

What 11 years of data from nearly 29,000 kidney patients tells us about anemia treatment today

What New Research Says About “Uremic Toxins”

Real labs, real meals: what 15 days of tracking with the MetaSano app did to my creatinine and eGFR.

Your skin reflects your internal chemistry

A new meta-analysis of more than 5,800 adults aged 65 and older shows that SGLT2 inhibitors significantly slow kidney disease progression, reduce the risk of heart failure and cardiovascular death.

Discover three science-backed foods that nourish your kidneys instead of focusing only on what to avoid.